|
EQS-News: MEDICLIN AG
/ Key word(s): Disposal/Miscellaneous
MEDICLIN Herzzentrum Coswig: Transfer of operations on 1 April
Offenburg, 28 March 2024: The operation of the MEDICLIN Herzzentrum Coswig will be transferred to Johannesstift Diakonie on 1 April 2024, as all conditions of the contract of sale have been met. Prof. Dr Lutz Fritsche (Chief Medical Officer of Johannesstift Diakonie), Dr Joachim Ramming (CEO of MEDICLIN) and Andreas Mörsberger (Spokesman of the Management Board and Chief Financial Officer of Johannesstift Diakonie) met to sign the agreement in February. "From 1 April, the MEDICLIN Herzzentrum Coswig will now operate under the name "Evangelisches Herzzentrum Coswig"," Ramming tells the local staff. "But even under the new ownership and with a new name, people in the region will recognise the clinic as a place where they receive the best possible care in all areas and at all times. We wish our colleagues in Coswig all the best for the future." About the MEDICLIN Herzzentrum Coswig The MEDICLIN Herzzentrum Coswig is an interdisciplinary centre for cardiovascular medicine. The facility unites the Clinic for Cardiovascular Surgery, the Clinic for Cardiology and Angiology and the Clinic for Anaesthesiology and Intensive Care Medicine under one roof. The clinic, which opened in 1998, has 113 beds and employs around 340 staff. For further information: MEDICLIN Aktiengesellschaft Okenstrasse 27 77652 Offenburg Investor Relations Ender Gülcan Phone: 0781/488-326 Fax: 0781/488-184 ender.guelcan@mediclin.de Public Relations Dr Janina Lossen Phone: 0781/488-180 janina.lossen@mediclin.de www.mediclin.de About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510) MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs. MEDICLIN ─ a company of the Asklepios Group
28.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | MEDICLIN AG |
| Okenstraße 27 | |
| 77652 Offenburg | |
| Germany | |
| Phone: | +49 (0)781 488-326 |
| Fax: | +49 (0)781 488-184 |
| E-mail: | ender.guelcan@mediclin.de |
| Internet: | www.mediclin.de |
| ISIN: | DE0006595101 |
| WKN: | 659510 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1870067 |
| End of News | EQS News Service |
|
|
1870067 28.03.2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
